The medical devices industry continues to be a hotbed of innovation. Activity is driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, as well as a growing importance of technologies such as machine learning, augmented reality, 5G and digitalisation. In the last three years alone, there have been over 450,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Robotics in Medical Devices: Robotic tissue ablation. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s Technology Foresights, which uses over 550,000 patents to analyse innovation intensity for the medical devices industry, there are 150+ innovation areas that will shape the future of the industry.
Robotic tissue ablation is a key innovation area in robotics
Robotic tissue ablation is a clinical procedure of removing or destroying the diseased tissue or tumour from the body, with the help of a robotic surgical arm. This technique avoids conventional manual ablation methods, with its superiority, driven by increased precision, stability, and efficacy. It also assures safety from potential human errors.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 110+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of robotic tissue ablation.
Key players in robotic tissue ablation – a disruptive innovation in the medical devices industry
‘Application diversity’ measures the number of different applications identified for each relevant patent. It broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in. It reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to robotic tissue ablation
Source: GlobalData Patent Analytics
Johnson & Johnson is one of the leading patent filers in the field of robotic tissue ablation. Some other key patent filers in the field include Medtronic, Intuitive Surgical, and Abbott Laboratories.
In terms of application diversity, CereVasc leads the pack, followed by Waters and US Patent Innovations. By means of geographic reach, Creo Medical Group held the top position, followed by Clearpoint Neuro and Gynesonics in second and third spots, respectively.
With extremely low risk of complications, the cost and benefits of robotic tissue ablation are noteworthy. The procedures provide exceptional precision, speedy healing, and excellent outcomes, making it a dominant innovation in the field of medicine. In the near future, the market for surgery is expected to be driven by robotic tissue ablation, which will surpass traditional ablation surgery methods.
To further understand how robotics is disrupting the medical devices industry, access GlobalData’s latest thematic research report on Robotics in Medical (2021).
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
